Abiopharma

🔍 Chan Heng Fai Ambrose (Director)

Company: HWH International Inc. (HWH)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Acquired 1,480,000 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,482,600.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: On August 7, 2026, the Board of Directors of HWH International Inc. (the "Company") awarded the Company's Chairman and Chief Executive Officer Chan Heng Fai 1,480,000 shares of the Company's common stock (the "Shares"). The Shares were granted to Mr. Chan as compensation for services rendered to the Company pursuant to the Company's 2025 Incentive Compensation Plan, as amended. The Shares are subject to a lockup for twelve months from the date of issuance.
• F2: The Chairman, Chief Executive Officer and majority stockholder of Alset Inc., Chan Heng Fai, may also be deemed to possess beneficial ownership of shares of the Issuer owned by Alset Inc. Alset Inc. beneficially owns 5,581,719 shares of the Issuer's common stock, including 2,787,590 shares owned directly, 2,211,279 shares owned indirectly through its majority owned subsidiary Alset International Limited, and 535,475 shares and warrants exercisable into 47,375 shares owned indirectly through another majority owned subsidiary of Alset Inc., Alset Acquisition Sponsor, LLC. Mr. Chan owns 2,482,600 shares of the Issuer's common stock personally.